Nemvaleukin plus Keytruda fails in Phase 3 trial in ovarian cancer
Interim data from a Phase 3 trial failed to…
Gynecological cancer encompasses a group of cancers affecting the female reproductive system. Approximately 100,000 people are diagnosed with gynecological cancer in the U.S. every year. Although each type of gynecological cancer is unique, with its own symptoms, risk factors, and treatment options, reaching an early diagnosis is critical for ensuring the best possible outcomes in any of them.
Read moreThere are several treatment approaches for gynecological cancer, which encompasses all cancers that originate in the female reproductive system. The choice of treatment will depend on the cancer type, how far it has spread, a patient’s general health status, and other factors, such as whether the patient wishes for their fertility to be preserved.
Read moreInterim data from a Phase 3 trial failed to…
Treatment with AbbVie’s Elahere (mirvetuximab soravtansine) reduced the risk…
A Phase 1 clinical trial testing Nikang Therapeutics’…
In a rare case, a woman in China was…
Allarity Therapeutics will soon start recruiting patients at…
The U.S. Food and Drug Administration (FDA) has granted…